Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Aubreyon Apr 14, 2015 9:08pm
133 Views
Post# 23630102

TLC 2000

TLC 2000  Thanks Mr Bencro for the info on the IBM Watson system. On a similar theme the TLC 2000 has software which enables practicioners to share their protocols and treatment results for various conditions (improves acuracy, precision and confidence) and saves time with other features which make it compatible with current medical administration systems in the USA. The systems design and function was determined via direct feedback from the pro groups who use the TLC1000 in response to what was needed for this ideal next generation system. 
   
 Glad to see the new ambitious marketing manager on board. Dear Mr Chan, lets get the sales going....we expect the use of the TLC 2000 to expand into post operative care and other areas. Hopefully we get some traction here...sooner the better,,,the investors are all falling asleep.  Cheers  
  
  
Bullboard Posts